September 5 - 8, 2014 - Rochester, MN

Course Directors: Friedman, Paul A., M.D. | Munger, Thomas M., M.D.

Program Schedule

Program schedules are subject to change without notice.

Friday, September 5

TimeTopic
7:00 a.m.Registration and Continental Breakfast
Leighton Auditorium, Siebens Building
7:30 a.m.Welcome and Introduction
Thomas M. Munger, M.D.
7:45 a.m.Understanding the Cardiac Action Potential of the Human Heart
Michael J. Ackerman, M.D., Ph.D.
8:45 a.m.Pharmacokinetics, Dynamics, Genetics, and Clinical EP of Antiarrhythmic Drugs
Hon-Chi Lee, M.D.
9:45 a.m.Refreshment Break
10:00 a.m.The Congenital Long QT Syndromes
Michael J. Ackerman, M.D., Ph.D.
11:00 a.m.The Other Cardiac Channelopathies
Michael J. Ackerman, M.D., Ph.D.
12:00 p.m.Lunch
12:15 p.m.Working Lunch: Clinical EP Basics: Electrogram Recording, Mapping,
and Ablation Biophysics
Siva K. Mulpuru, M.D.
12:45 p.m.SVT I: WPW, ART, Mahaim
Samuel J. Asirvatham, M.D.
1:45 p.m.Refreshment Break
2:15 p.m.AVNRT
Samuel J. Asirvatham, M.D.
3:15 p.m.Workshop: SVT Cases in the EP Lab: When Maneuvers Can Help
Samuel J. Asirvatham, M.D.
4:15 p.m.Refreshment Break
4:30 p.m.AT and Atrial Flutter: Mapping Systems and Ablation
William G. Stevenson, M.D.
5:30 p.m.Pharmacologic Therapy for Atrial Fibrillation
Yong-Mei Cha, M.D.
6:15 p.m.Dinner
6:30 p.m.Working Dinner: AF Ablation Cases: PV Potentials and Maneuvers
Douglas L. Packer, M.D.
7:15 p.m.AF and AFL Cases
Yong-Mei Cha, M.D.
7:45 p.m.EP Jeopardy
Thomas M. Munger, M.D.
8:30 p.m.Adjourn

Saturday, September 6

TimeTopic
7:00 a.m.Continental Breakfast
7:30 a.m.Entrainment and Catheter Ablation Structural Heart Disease (CAD)
William G. Stevenson, M.D.
8:30 a.m.VT Workshop of Unknown Cases
William G. Stevenson, M.D.
9:30 a.m.VT Syndromes – ARVD, RVOT, BBR, ILVT
Paul A. Friedman, M.D.
10:30 a.m.Refreshment Break
11:00 a.m.Congenital Arrhythmia Basics
Christopher J. McLeod, M.B., Ch.B., Ph.D.
11:30 a.m.Pacemaker Basics and Time Cycles
Raul E. Espinosa, M.D.
12:30 p.m.Lunch
12:45 p.m.Working Lunch: SVT Unknown Cases
Siva K. Mulpuru, M.D.
1:45 p.m.ICD Troubleshooting Part 1
Paul A. Friedman, M.D.
2:15 p.m.Refreshment Break
2:45 p.m.ICD Troubleshooting Part 2
Charles Swerdlow, M.D.
3:45 p.m.Case-Based Workshop: Device Cases I
David J. Bradley, M.D., Ph.D. and Siva K. Mulpuru, M.D.
4:45 p.m.Device Workshop II
Siva K. Mulpuru, M.D. and Christopher J. McLeod, M.B., Ch.B., Ph.D.
5:45 p.m.Dinner
6:00 p.m.Working Dinner: ABIM Module 1
Paul A. Friedman, M.D., Hon-Chi Lee, M.D., Thomas M. Munger, M.D., and Win-Kuang Shen, M.D.
8:00 p.m.Adjourn

Sunday, September 7

TimeTopic
7:30 a.m.Continental Breakfast
8:00 a.m.Applying the Basics Workshop: Basic Electrophysiology
Hon-Chi Lee, M.D.
9:00 a.m.Syncope
Win-Kuang Shen, M.D.
10:00 a.m.Refreshment Break
10:30 a.m.Avoiding Complications During Atrial Fibrillation Ablation
Thomas M. Munger, M.D.
11:30 a.m.Lunch
11:45 a.m.Working Lunch: ABIM Module 2
Paul A. Friedman, M.D., Hon-Chi Lee, M.D., Thomas M. Munger, M.D., and Win-Kuang Shen, M.D.
1:45 p.m.Course Adjourns

Monday, September 8

TimeTopic
7:30 a.m.Continental Breakfast
8:30 a.m.Transportation provided to St. Marys Hospital for workshop
4:00 p.m.Adjourn

Faculty

Course Directors

  • Paul A. Friedman, M.D.
  • Thomas M. Munger, M.D.

Mayo Clinic Faculty

  • Michael J. Ackerman, M.D., Ph.D.
  • Samuel J. Asirvatham, M.D.
  • David J. Bradley, M.D., Ph.D.
  • Yong-Mei Cha, M.D.
  • Raul E. Espinosa, M.D.
  • Hon-Chi Lee, M.D., Ph.D.
  • Christopher J. McLeod, M.B., Ch.B., Ph.D.
  • Siva K. Mulpuru, M.D.
  • Douglas L. Packer, M.D.
  • Win-Kuang Shen, M.D.

Guest Faculty

  • William G. Stevenson, M.D.
  • Charles D. Swerdlow, M.D.

 

Faculty Disclosure

As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of Continuous Professional Development) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.